Blood Pressure Lowering Effects of Amosartan Regarding Proviso iN Patients With High Blood Pressure
NCT03255551 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 50
Last updated 2017-08-21
Summary
Blood Pressure Lowering Effects of Amosartan Regarding Proviso in Patients with Hypertension
Conditions
Interventions
- DRUG
-
Amosartan
amosartan is a combination of amlodipine, which is a calcium channel blocker (CCB), and rozatan, an angiotensin II receptor antagonist (ARB), and is an antihypertensive agent
Sponsors & Collaborators
-
Seoul National University Bundang Hospital
lead OTHER
Eligibility
- Min Age
- 18 Years
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2014-01-01
- Primary Completion
- 2015-06-30
- Completion
- 2015-12-31
More Related Trials
-
Comparison of Blood Pressure Lowering Effect Between Fimasartan and Losartan
NCT02958631 ·Status: UNKNOWN ·Phase: PHASE4
-
Fimasartan/Amlodipine Combination Phase III
NCT02152306 ·Status: COMPLETED ·Phase: PHASE3
-
An Observation Study on the Identification of Prescription Patterns of Lodient Tab(Telmisartan/S-amlodipine)
NCT06214832 ·Status: RECRUITING
-
Clinical Efficacy and Safety Evaluation of Irbesartan High and Amlodipine Combined Therapy in Essential Hypertension Patients
NCT05475665 ·Status: COMPLETED ·Phase: PHASE3
-
Effect of Olmesartan on Angiotensin(1-7) Levels and Vascular Functions in Diabetes and Hypertension
NCT05189015 ·Status: COMPLETED ·Phase: PHASE4
-
Irbesartan/Amlodipine in Hypertensive Patients Uncontrolled on Irbesartan 150 mg Monotherapy
NCT00957554 ·Status: COMPLETED ·Phase: PHASE3
-
S-amlodipine in Essential HypertensIon and Assessment of Blood Pressure Targets Achievement
NCT06130124 ·Status: UNKNOWN
-
A Phase 2 Study to Assess Dose-response Relationship of HCP1803 in Patients With Essential Hypertension
NCT03897868 ·Status: COMPLETED ·Phase: PHASE2
-
Comparision of Blood Pressure Variability Between Amlodipine and Losartan
NCT01964079 ·Status: COMPLETED ·Phase: PHASE4
-
A Randomized, Open-label, Single Dose, Two-way Crossover Clinical Trial to Compare the Safety, Pharmacokinetic Profiles of UI15AML055MT and Amosartan® Tablet 5/50 mg After a Single Oral Administration in Healthy Male Volunteers
NCT02166398 ·Status: COMPLETED ·Phase: PHASE1
-
Fimasartan Optimal Reduction Targeting Elevated Blood Pressure: the FORTE Study
NCT03254914 ·Status: COMPLETED
-
Phase 2 Study to Evaluate the Efficacy and Safety of Irbesartan and Amlodipine Combined or Alone in Patients With Essential Hypetension
NCT04488978 ·Status: COMPLETED ·Phase: PHASE2
-
A Study to Evaluate the Efficacy and Safety of HCP2102 in Essential Hypertension Patients
NCT05450601 ·Status: COMPLETED ·Phase: PHASE3
-
Efficacy/Safety of Amlodipine Plus Losartan Versus Amlodipine in Patients With Stage 2 Hypertension
NCT01127217 ·Status: COMPLETED ·Phase: PHASE3
-
A Phase 2 Study to Explore the Dose of HCP1803 in Patients With Essential Hypertension
NCT04959305 ·Status: COMPLETED ·Phase: PHASE2
-
Efficacy/Safety of Amlodipine Plus Losartan Versus Losartan in Patients With Essential Hypertension
NCT00940680 ·Status: COMPLETED ·Phase: PHASE3
-
Clinical Efficacy and Safety Evaluation of Irbesartan and Amlodipine Combined Therapy in Essential Hypertension Patients
NCT05476354 ·Status: COMPLETED ·Phase: PHASE3
-
Efficacy/Safety of Amlodipine Plus Losartan Versus Amlodipine in Patients With Essential Hypertension
NCT00940667 ·Status: COMPLETED ·Phase: PHASE3
-
Blood Pressure Lowering Ability and Safety of an Olmesartan and Amlodipine Based Treatment Regimen in Patients With Stage I and Stage II Hypertension
NCT00527514 ·Status: COMPLETED ·Phase: PHASE3
-
Efficacy and Safety of Telmisartan and Losartan in Primary Hypertension
NCT02269176 ·Status: COMPLETED ·Phase: PHASE3
-
Diurnal Variation in Hypertensive Stroke Patients
NCT01830517 ·Status: COMPLETED ·Phase: PHASE4
-
Study to Evaluate and Compare the Efficacy and Safety of AZM and AML Combined and Alone in Mild-to-moderate Essential Hypertensive Subjects
NCT05385770 ·Status: COMPLETED ·Phase: PHASE3
-
A Study to Evaluate Efficacy and Safety of HCP1401 for Stage 2 Hypertension Patients Not Controlled by HCP0605
NCT02916602 ·Status: COMPLETED ·Phase: PHASE3
-
Hydrochlorothiazide (+) Losartan Potassium vs. Amlodipine Comparative Study (0954A-314)
NCT00157963 ·Status: COMPLETED ·Phase: PHASE4
-
Clinical Efficacy and Safety Evaluation of HCP1904-1 in Essential Hypertension Patients
NCT04820907 ·Status: COMPLETED ·Phase: PHASE3